Palliative care in urology.
Surg. Clin. North Am., Apr;91(2):429-44, x (2011)
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention.
Ann. Surg., Aug;254(2):333-8 (2011)
Creating the future biomedical research workforce.
Sci Transl Med., Sep;3(102):102fs5 (2011)
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.
Cancer., Mar;112(5):1162-8 (2008)
Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force.
Acad Med., Dec;82(12):1211-9 (2007)
The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
Liver Transpl., Aug;14(8):1100-6 (2008)
Cardiovascular disease in women--challenges deserving a comprehensive translational approach.
J Cardiovasc Transl Res., Sep;2(3):251-5 (2009)
Radical palliative surgery: new limits to pursue.
Pediatr. Surg. Int., Oct;25(10):917-21 (2009)
Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials.
J Palliat Med., Apr;14(4):465-73 (2011)
Hospice care for the incarcerated in the United States: an introduction.
J Palliat Med., Aug;5(4):549-52 (2002)
Prison hospice and pastoral care services in California.
J Palliat Med., Dec;5(6):903-8 (2002)
Current strategies in the management of hormone refractory prostate cancer.
Cancer Treat. Rev., Jun;29(3):171-87 (2003)
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
Clin. Cancer Res., Oct;9(13):4772-81 (2003)
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma.
Cancer., Jan;100(1):82-8 (2004)
The TLC model of palliative care in the elderly: preliminary application in the assisted living setting.
Ann Fam Med., 2(1):54-60 (2004)
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
Cancer., May;100(10):2125-31 (2004)
A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation.
Transpl. Int., Sep;17(8):473-5 (2004)
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.
Cancer J., 10(5):294-300 (2004)
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
J Pain Symptom Manage., Dec;28(6):548-56 (2004)
An approach to develop effective health care decision making for women in prison.
J Palliat Med., Apr;8(2):432-9 (2005)
The Palliative Care in Assisted Living (PCAL) pilot study: successes, shortfalls, and methodological implications.
Soc Sci Med., Jan;62(1):199-207 (2006)
Medical and surgical palliative care of patients with urological malignancies.
J. Urol., Oct;174(4 Pt 1):1177-82 (2005)
Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature.
J Support Oncol., Oct;4(9):460-2, 464; discussion 463-4 (2006)
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
J. Clin. Oncol., Mar;19(6):1728-33 (2001)
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Clin. Cancer Res., Jun;7(6):1561-8 (2001)
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
Prostate., Jan;50(1):27-37 (2002)
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.
Cancer., May;94(10):2584-9 (2002)
Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
Cancer., Sep;95(5):1009-15 (2002)
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.
Leukemia., Jul;9(7):1126-9 (1995)
A three-point approach to anemia.
Postgrad Med., Feb;89(2):179-83, 186 (1991)
On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years.
J. Autoimmun., May;30(3):180-96 (2008)
The immunobiology of mushrooms.
Exp. Biol. Med. (Maywood)., Mar;233(3):259-76 (2008)
Probiotics and immunity.
J. Gastroenterol., 44(1):26-46 (2009)
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer.
Invest New Drugs., 16(2):179-82 (1998)
Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Semin. Oncol., Oct;24(5 Suppl 15):S15-68-S15-71 (1997)
Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).
Invest New Drugs., 16(4):347-51 (1998)
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome.
Cancer., Aug;86(4):684-8 (1999)
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
Urology., Apr;55(4):521-5 (2000)
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.
Prostate., Aug;44(3):187-92 (2000)
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.
J. Clin. Oncol., May;15(5):1858-69 (1997)
Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
Cancer., Dec;80(12 Suppl):2576-82 (1997)
Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study.
Breast Cancer Res. Treat., Sep;51(2):169-81 (1998)
Treatment options in androgen-independent prostate cancer.
Cancer Invest., 17(2):137-44 (1999)
The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis.
J Gen Intern Med., May;12(5):318-31 (1997)
A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group.
Int. J. Radiat. Oncol. Biol. Phys., Apr;38(1):83-94 (1997)
Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.
Urology., May;47(5):652-7 (1996)
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study.
Am. J. Clin. Oncol., Oct;18(5):400-2 (1995)
Screening for cancer. Is it worth it?
West. J. Med., Aug;163(2):166-8 (1995)
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
J. Clin. Oncol., Jun;13(6):1303-11 (1995)
Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Cancer Biother., 10(3):205-9 (1995)
Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
Cancer., Jun;71(11):3509-13 (1993)
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
Invest New Drugs., 11(2-3):207-9 (1993)
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study.
J. Urol., Jul;148(1):52-4 (1992)
A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2.
Clin. Pharmacol. Ther., Mar;49(3):307-13 (1991)
An outpatient approach to the delivery of intensive consolidation chemotherapy to adults with acute lymphoblastic leukemia.
Oncol Nurs Forum., 17(4):553-8 (1990)
Improved approach to patients with normocytic anemia.
Am Fam Physician., Aug;38(2):191-5 (1988)
Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group.
J. Clin. Oncol., Jun;5(6):951-5 (1987)
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
Cancer Res., Jul;46(7):3722-7 (1986)
Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Cancer Treat Rep., Jan;69(1):143-4 (1985)
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.
J. Clin. Oncol., Nov;3(11):1463-70 (1985)
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
J. Urol., Dec;134(6):1118-21 (1985)
Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study.
Cancer Treat Rep., Jun;70(6):805-6 (1986)